title: Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis.
authors.forename: Tihana
authors.initials: T
authors.lastname: Bicanic
authors.forename: Robin
authors.initials: R
authors.lastname: Wood
authors.forename: Linda-Gail
authors.initials: LG
authors.lastname: Bekker
authors.forename: Marta
authors.initials: M
authors.lastname: Darder
authors.forename: Graeme
authors.initials: G
authors.lastname: Meintjes
authors.forename: Thomas S
authors.initials: TS
authors.lastname: Harrison
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D004198:Disease Susceptibility; D005437:Flucytosine / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016919:Meningitis, Cryptococcal / Q000188:drug therapy* / Q000453:epidemiology; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents; D000666:Amphotericin B; D005437:Flucytosine